When was LaCell founded?

LaCell was founded in 2010 and raised its 1st funding round 2 years after it was founded.

Where is LaCell located?

LaCell is headquartered in New Orleans, United States.

How many employees does LaCell have?

As of Mar 01, 2026, the latest employee count at LaCell is 10 - 49.

Is LaCell a funded company?

LaCell is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 01, 2012.

When was the latest funding round of LaCell?

LaCell's latest funding was a $***** Grant (prize money) round on Jul 01, 2016, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.23B in funding in 2026 to date.

Where does LaCell rank among its competitors?

LaCell ranks 30th amongst 213 active competitors, of which 29 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of LaCell?

LaCell's top competitors include BioLife Solutions, Integrated DNA Technologies and RoosterBio. Among them, BioLamina secured the most recent funding round in April, 2026.

LaCell - 2026 Company Profile, Team, Funding & Competitors

LaCell is a funded company based in New Orleans (United States), founded in 2010 by Jeffrey Gimble. It operates as a Human-derived biomaterials and organ-on-a-chip models for preclinical drug development. LaCell has raised an undisclosed amount in funding. The company has 213 active competitors, including 29 funded and 39 that have exited. Its top competitors include companies like BioLife Solutions, Integrated DNA Technologies and RoosterBio.

Company Details

Human-derived biomaterials and organ-on-a-chip models for preclinical drug development. They are a life sciences manufacturer specializing in human-derived hydrogels, stem cells, and functional fat-on-a-chip models. Their technology empowers research with adipose tissue models that incorporate human diversity and mimic human biology, offering deeper insights into metabolic diseases. They provide tools for advancing science, streamlining the translation from research and development to clinical trials. Their offerings include cell culture media, stem cells, hydrogels, and fat-on-a-chip kits and services. They envision a world where enriched preclinical insights create future therapies that are accessible, equitable, and effective for patients worldwide. They foster innovation through strategic partnerships.

Website: lacell-usa.com
Email ID: *****@lacell-usa.com
Phone Number: +1 **********
Part Of

Key Metrics

Founded Year

2010

Location

New Orleans, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Jul 01, 2016, $*****

Investors

National Science Foundation & 2 more

Ranked

30^th among 213 active competitors

Employee Count

10 - 49 as on Mar 01, 2026

Similar Companies

BioLife Solutions & 279 more

View LaCell's full profile

LaCell has raised funding over 2 rounds. Its first funding round was on Aug 01, 2012. Its latest funding round was a Grant (prize money) round on Jul 01, 2016 for $*****. 1 investor participated in its latest round. LaCell has 3 institutional investors.

Here is the list of recent funding rounds of LaCell:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 01, 2016	2060865	Grant (prize money)	8647578	5266511	5606403	5808809
Aug 01, 2012	6196299	Grant (prize money)	9154810	1542332	8343035	HHS

Access funding benchmarks and valuations. Sign up today!

View details of LaCell's funding rounds and investors

The founders of LaCell is Jeffrey Gimble.

Here are the details of LaCell's key team members:

Jeffrey Gimble: Co-Founder & CSO of LaCell and founder of 1 other company.
Contact Info: 2 email addresses

View details of LaCell's Founder profiles and Board Members

LaCell's employee count trend

LaCell has 10 - 49 employees as of Mar 26. Here is LaCell's employee count trend over the years:

Uncover LaCell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LaCell include BioLife Solutions, Integrated DNA Technologies and RoosterBio. Here is the list of Top 10 competitors of LaCell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BioLife Solutions 1987, Bothell (United States), Acquired	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
2nd	Integrated DNA Technologies 1987, Coralville (United States), Acquired	Provider of oligonucleotide-based reagents and kits	-	Summit Partners, Golub Capital & 1 others	63/100
3rd	RoosterBio 2012, Frederick (United States), Series B	Developer of human mesenchymal stem cells and extracellular vesicles	$38.4M	Planetary Technologies, Dynamk Capital & 4 others	57/100
4th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
5th	Acorn 2017, Toronto (Canada), Series A	Provider of stem cell biobanking services	$3.33M	TELUS Ventures, Accelerator Centre & 5 others	55/100
6th	StemCyte 1997, Covina (United States), Public	Cord blood banking and regenerative therapeutics company focused on saving lives	$23.3M	penbank.com, Montage Capital & 7 others	53/100
7th	Shanghai Doning Biotechnology 2005, Shanghai (China), Series C	Provider of cell culture media	$14.9M	HongShan, Ally Bridge Group & 1 others	53/100
8th	ArcticZymes 2009, Tromso (Norway), Public	Developer of recombinant enzymes from various arctic species	-	Northislet, Europa	49/100
9th	Toyobo 1882, New York City (United States), Public	Manufacturer of high performance materials including films and functional textiles	-	-	49/100
10th	Cryo-Cell 1989, Oldsmar (United States), Public	Provider of a cord blood bank to store stem cells	$2.9M	-	47/100
30th	LaCell 2010, New Orleans (United States), Funding Raised	Human-derived biomaterials and organ-on-a-chip models for preclinical drug development	-	National Science Foundation, HHS & 1 others	38/100